انتقل إلى المحتوى الرئيسي
الترجمة جارية — يُعرض هذا المحتوى باللغة الإنجليزية أثناء إعداد نسختك بلغتك.
العودة إلى النقاشات

يجب على ترامب إنهاء عملية التستر التي استمرت 25 سنة من قبل إدارة الغذاء والدواء على حبة الإجهاض

Politics
United States
بدأ في February 15, 2026

Mifepristone has not gotten safer; the FDA has just gotten more political

مقالات المصادر

إضافة تصريح التحليل 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
5 تصريحات للتصويت • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM نشر بواسطة will • Feb 15, 2026
The discussion around mifepristone reflects broader societal debates on reproductive rights, necessitating an open dialogue about women's healthcare options.

الترجمة قيد الإعداد

Vote options for this statement: agree, disagree, or unsure
💬 عرض النقاش
Be first to respond
Vote to see results
CLAIM نشر بواسطة will • Feb 15, 2026
Mifepristone has been proven safe and effective; any claims of a cover-up undermine the trust in our healthcare system and the FDA's rigorous processes.

الترجمة قيد الإعداد

Vote options for this statement: agree, disagree, or unsure
💬 عرض النقاش
Be first to respond
Vote to see results
CLAIM نشر بواسطة will • Feb 15, 2026
The FDA's approval of mifepristone should be reevaluated to ensure safety standards are upheld, prioritizing women's health above political agendas.

الترجمة قيد الإعداد

Vote options for this statement: agree, disagree, or unsure
💬 عرض النقاش
Be first to respond
Vote to see results
CLAIM نشر بواسطة will • Feb 15, 2026
Ending the FDA's oversight on mifepristone could set a dangerous precedent, allowing political influence to dictate medical safety regulations.

الترجمة قيد الإعداد

Vote options for this statement: agree, disagree, or unsure
💬 عرض النقاش
Be first to respond
Vote to see results
CLAIM نشر بواسطة will • Feb 15, 2026
The debate over mifepristone highlights the need for balanced regulatory practices that consider both safety and access to reproductive healthcare.

الترجمة قيد الإعداد

Vote options for this statement: agree, disagree, or unsure
💬 عرض النقاش
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us